The Journal of Organic Chemistry
Article
6.81−6.79 (m, 2H), 6.71−6.68 (m, 1H), 6.62−6.59 (m, 2H), 5.03 (d,
2H, J = 6.8 Hz), 2.54−2.37 (m-2H), 2.27 (s, 6H), 2.20 (s, 6H), 1.82−
1.74 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 143.2, 137.5 (d, JC,P = 7
Hz), 137.3 (d, JC,P = 7 Hz), 133.1, 131.8 (d, JC,P = 20 Hz), 131.3 (d, JC,P
= 19 Hz), 130.2, 128.3 (d, JC,P = 4 Hz), 128.2, 126.6, 126.5, 126.1,
124.2 (d, JC,P = 4 Hz), 65.3, 31.4, 21.3, 21.2; 31P NMR (161.7 MHz,
CDCl3) δ −14.7; m/z (CI) 782 (M+); HRMS (CI) m/z calcd for
C39H39N2P 566.2851, found 566.2847.
flask containing [PdCl2(CH3CN)2] (0.3 mmol, 75 mg). The reaction
mixture was stirred at room temperature overnight, concentrated
to dryness, washed with n-pentane, and dried in vacuo to give the
palladium dichloride complex. Yields and characterization data for
compounds 10a−c are as follows:
(2S,5S)-1-[2-(Diphenylphosphino)benzylideneamino]-2,5-di-
phenylpyrrolidine PdCl2 complex (10a). Prepared according to
the general procedure, 10a was obtained as an orange solid (167 mg,
84%). X-ray quality crystals were grown by slow diffusion of n-hexane
(2S,5S)-1-[2-(Di-4-fluorophenylphosphino)benzylideneamino]-
2,5-diphenylpyrrolidine (2g). Following the general procedure,
into a solution of 10a in CH2Cl2: mp = 206−208 °C dec; [α]20
=
D
−806.7 (c 0.3, CHCl3); 1H NMR (500 MHz, CD2Cl2, 25 °C) δ 7.46−
7.03 (m, 22H), 6.92 (dd, 1H, J = 7.5, 4.5 Hz), 6.76 (dd, 1H, J = 10.2,
8.1 Hz), 6.09 (br s, 2H), 2.61 (br s, 2H), 1.82 (br s, 2H); 13C NMR
flash chromatography (EtOAc/n-hexane 1:20) gave 2g (587 mg, 78%)
1
as a white foam: [α]20 −108.3 (c 0.9, CHCl3); H NMR (400 MHz,
D
CDCl3) δ 7.64−7.61 (m, 1H), 7.37−7.30 (m, 2H), 7.26−7.14 (m,
6H), 7.14−7.07 (m, 6H), 7.04−6.97 (m, 4H), 6.91−6.81 (m, 3H),
6.61−6.58 (m, 1H), 5.02 (d, 2H, J = 6.8 Hz), 2.53−2.42 (m, 2H),
1.81−1.73 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 143.1, 135.9 (dd,
J = 21, 8 Hz), 135.3 (dd, J = 21, 8 Hz), 134.0 (d, J = 20 Hz), 133.7 (d,
J = 20 Hz), 133.0, 132.6, 129.9, 128.8, 128.6, 128.5, 128.4, 128.3,
128.2, 126.7, 126.6, 126.4, 126.1, 126.0, 124.8 (d, JC,P = 4 Hz), 65.2,
31.4; 31P NMR (161.7 MHz, CDCl3) δ −16.2; m/z (CI) 546 (M+);
HRMS (CI) m/z calcd for C35H29F2N2P 546.2036, found 546.2035.
(2S,5S)-1-[2-(Di-o-tolylphosphino)benzylideneamino)-2,5-di-
phenylpyrrolidine (2h). Following the general procedure, flash
chromatography (toluene/n-hexane 1:2) gave 2h (635 mg, 85%) as a
light yellow foam: [α]20D −138.2 (c 1.2, CHCl3); 1H NMR (400 MHz,
CDCl3) δ 7.70 (dd, 1H, J = 7.3 and 4.3 Hz), 7.50 (d, 1H, J = 5.5 Hz),
7.24−7.23 (m, 5H), 7.20−7.17 (m, 4H), 7.12−7.10 (m, 3H), 7.07−
7.05 (m, 1H), 6.95 (t, 2H, J = 7.3 Hz), 6.68 (dd, 1H, J = 6.8, 4.3 Hz),
6.60 (dd, 1H, J = 7.0, 4.5 Hz), 6.54 (dd, 1H, J = 6.8, 4.3 Hz), 5.02 (d,
2H, J = 6.5 Hz), 2.49−2.45 (m-2H), 2.27 (s, 3H), 2.06 (s, 3H), 1.78−
(125 MHz, CD2Cl2, 25 °C) δ 140.3 (d, JC−P = 8 Hz), 138.5 (d, JC−P
=
14 Hz), 134.7, 134.6, 134.0 (d, JC−P = 11 Hz), 133.7 (d, JC−P = 9 Hz),
133.1, 132.8 (d, JC−P = 11 Hz), 132.4, 131.7, 130.5 (d, JC−P = 8 Hz),
129.5 (d, JC−P = 12 Hz), 129.3, 129.1, 128.8 (d, JC−P = 12 Hz), 128.2
(d, JC−P = 11 Hz), 128.0, 127.8, 126.4, 124.6 (d, JC−P = 51 Hz), 117.8
(d, JC−P = 51 Hz), 67.4 (br s), 32.2; 31P NMR (202.4 MHz, CD2Cl2)
δ +28.1. m/z (CI) 616 (M+ − 2 Cl, 4), 511 (13), 288 (100); HRMS
(CI) m/z calcd for C35H31N2PPd 616.1260, found 616.1274.
(2S,5S)-1-[2-(Diphenylphosphinobenzylideneamino]-2,5-di-
phenylpiperidine PdCl2 Complex (10b). Prepared according to the
general procedure, starting from 2b (0.23 mmol, 118 mg) and
[PdCl2(CH3CN)2] (0.23 mmol, 59 mg), 10b was obtained as an
orange solid (147 mg, 91%): mp = 178−180 °C; [α]20D = −261.8 (c 0.3,
CHCl3); 1H NMR (300 MHz, CDCl3, 25 °C): δ 7.67−6.95 (m, 24H),
6.72 (dd, 1H, J = 9.9, 7.8 Hz), 6.50 (br s, 1H), 2.10−1.92 (m, 2H),
1.70−1.55 (m, 2H), 1.50−1.36 (m, 2H); 13C NMR (75 MHz, CDCl3,
25 °C): δ 148.0 (d, JC−P = 9 Hz), 141.5, 136.8 (d, JC−P = 11 Hz), 134.2
(d, JC−P = 10 Hz), 134.0, 133.2 (d, JC−P = 10 Hz), 132.8 (d, JC−P = 12
Hz), 132.3 (d, JC−P = 20 Hz), 131.5, 131.0 (d, JC−P = 8 Hz), 129.0,
128.8, 128.1, 127.9 (d, JC−P = 13 Hz), 126.9 (br s), 126.0 (d, JC−P = 25
Hz), 125.2, 124.5 (d, JC−P = 51 Hz), 118.7 (d, JC−P = 51 Hz), 64.3, 29.6,
18.1; 31P NMR (161.7 MHz, CDCl3, 25 °C) δ + 28.5. m/z (FAB) 665
(M+ − Cl, 24), 629, 154; HRMS (FAB) m/z calcd for C36H33N2PClPd
665.1105, found 665.1112.
1.77 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 143.1, 142.4 (d, JC,P
26 Hz), 141.3 (d, JC,P = 17 Hz), 134.8 (d, JC,P = 46 Hz), 133.4 (d, JC,P
=
=
33 Hz), 132.9, 129.9 (d, JC,P = 5 Hz), 128.6, 128.4, 128.3, 126.8, 126.6,
126.1, 126.0, 125.9, 125.8, 124.2, 65.3, 31.4, 26.9; 31P NMR (202.4
MHz, CDCl3) δ −31.2. m/z (EI) 538 (M+); HRMS (EI) m/z calcdfor
C37H35N2P 538.2538, found 538.2540.
(2S,5S)-1-[2-(Dicyclohexylphosphoryl)benzylideneamino]-
2,5-diphenylpyrrolidine (18). Following the general procedure,
(2S,5S)-1-[2-(Diphenylphosphino)benzylideneamino]-2,5-
isopropylpyrrolidine PdCl2 Complex (10c). Prepared according to
the general procedure, 10c was obtained as an orange solid (160 mg,
89%). X-ray quality crystals were grown by slow diffusion of diethyl
flash chromatography (EtOAc/n-hexane 1:2) gave 18 (491 mg, 66%)
1
as a light yellow foam: [α]20 −100.0 (c 0.8, CHCl3); H NMR (500
D
MHz, CDCl3) δ 7.39−7.36 (m, 4H), 7.32−7.27 (m, 9H), 7.14 (br s,
1H), 5.26 (br s, 2H), 2.62−2.56 (m, 2H), 1.90−1.81 (m, 4H), 1.77−
1.45 (m, 8H), 1.42−0.85 (m, 12H); 13C NMR (125 MHz, CDCl3) δ
130.6, 128.5, 126.8, 126.4, 126.2, 125.2 (d, JC,P = 9 Hz), 65.3 (br s),
37.3 (d, JC,P = 67 Hz), 31.3, 26.5 (d, JC,P = 12 Hz), 26.4, 26.3, 26.2,
26.2, 26.1, 24.8; 31P NMR (202.4 MHz, CDCl3) δ + 50.5; HRMS (EI)
m/z calcd for C35H43N2OP 538.3113, found 538.3112.
ether into a solution of 10c in CH2Cl2: mp = 153−155 °C; [α]20
=
D
1
−1036.0 (c 0.4, CHCl3); H NMR (500 MHz, CDCl3, 25 °C) δ 7.60
(br s, 2H), 7.50−7.37 (m, 10H), 7.23 (t, 1H, J = 7.0 Hz), 7.09 (m,
1H), 6.68 (dd, 1H, J = 9.5, 8.1 Hz), 2.33 (br s, 2H), 1.89 (br s, 2H),
1.75 (br s, 2H), 1.65 (br s, 2H), 0.84 (br d, J = 5.4 Hz, 12 H); 13C
NMR (75 MHz, CDCl3, 25 °C) broad signals were observed at 295 K;
some peaks were not observed, δ 134.8 (d, JC−P = 10 Hz), 134.1, 133.1,
132.9, 132.6 (d, JC−P = 10 Hz), 132.0, 131.8, 129.9 (d, JC−P = 8 Hz),
(2S,5S)-1-[2-(Dicyclohexylphosphino)benzylideneamino]-
2,5-diphenylpyrrolidine (2i). To a stirred solution under argon of
18 (0.5 mmol, 269 mg) in dry toluene (8 mL) were added dry Et3N
(15 mmol, 2.1 mL) and HSiCl3 (7.5 mmol, 750 μL). The reaction
mixture was stirred at 110 °C for 24 h, satd NaHCO3 (1 mL) was
added, and the reaction crude was filtered through Celite and
concentrated to dryness. Flash chromatography (EtOAc/n-hexane
129.3 (d, JC−P = 11 Hz), 128.1 (d, JC−P = 12 Hz), 22.7, 19.6, 16.0; 31
P
NMR (161.7 MHz, CDCl3) δ +28.1; m/z (CI) 548 (M+ − 2Cl, 20),
442 (100); HRMS (CI) m/z calcd for C29H35N2PPd (M+ − 2Cl)
547.9210, found 547.9203.
Isolation of Intermediate 27a. Following a described procedure,6g
a Schlenk tube was charged inside a drybox with ligand 2a (0.1 mmol,
39 mg) and [Pd(cod)(CH2TMS)2] (0.1 mmol, 39 mg). The Schlenk
tube was placed outside the drybox, and after cycles of vacuum−argon,
a solution of 1-bromonaphthalene (0.1 mmol, 28 μL) in dry and
deoxygenated THF (3 mL) was transferred via cannula. The reaction
mixture was stirred overnight at rt, and the precipitation of a yellow solid
was observed. The mixture was concentrated to dryness, and the yellow
solid was washed with dry, deoxygenated n-hexane and dried in vacuum
to obtain 58 mg (70%) of product. X-ray quality crystals were obtained
by slow evaporation of a solution of 27a in CH2Cl2/acetone mixture:
mp = 160−162 °C dec; [α]20D = −267.0 (c 0.3, CHCl3); 1H NMR (400
MHz, CDCl3, 25 °C) a 1:1 mixture of diastereoisomers in the C−Pd
bond was observed at this temperature, δ 8.56 (t, 1H, J = 7.6 Hz), 7.52−
6.93 (m, 27H), 6.88 (br s, 1H), 6.73 (br s, 2H), 6.45−6.36 (br s, 2H),
6.21 (t, 1H, J = 8.8 Hz), 2.70 (br s, 2H), 1.80 (br s, 2H); 13C NMR
(75 MHz, CDCl3, 25 °C) broad signals were observed at 25 °C and
1:20) gave 2i (150 mg, 57%) as a yellow foam: [α]20 −82.2 (c 0.9,
D
CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.85 (d, 1H, J = 5.0 Hz), 7.75
(dd, 1H, J = 7.6, 3.0 Hz), 7.35−7.32 (m, 4H), 7.29−7.26 (m, 4H),
7.22−7.20 (m, 3H), 7.12 (t, 1H, J = 7.6 Hz), 7.05 (d, 1H, J = 7.6 Hz),
5.22 (d, 2H, J = 6.5 Hz), 2.61−2.52 (m, 2H), 1.88−1.72 (m, 4H),
1.70−1.55 (m, 4H), 1.53−1.39 (m, 4H), 1.36−1.15 (m, 8H), 1.05−
0.85 (m, 4H); 13C NMR (125 MHz, CDCl3) δ 143.7, 131.9 (d, JC,P
=
35 Hz), 128.4, 128.2, 126.6, 126.3, 125.5, 124.0 (d, JC,P = 4 Hz), 65.0,
34.0 (d, JC,P = 15 Hz), 32.1 (d, JC,P = 12 Hz), 31.4, 30.0 (br s), 29.7,
29.3, 34.0 (d, JC,P = 8 Hz), 27.9, 27.4 (d, JC,P = 14 Hz), 27.1 (d, JC,P = 8
Hz), 27.0 (d, JC,P = 13 Hz), 26.8 (d, JC,P = 9 Hz), 26.4, 26.1; 31P NMR
(202.4 MHz, CDCl3) δ −18.7; HRMS (EI) m/z calcd for C35H43N2P
522.3164, found 522.3162.
General Procedure for the Synthesis of Palladium Complexes
10a−c. A solution of 2a−c (0.3 mmol) in dry CH2Cl2 (5 mL) under
argon was transferred via cannula to a deoxygenated round-bottom
H
dx.doi.org/10.1021/jo300548z | J. Org. Chem. XXXX, XXX, XXX−XXX